Predictive value of MRI features on glioblastoma
- PMID: 37020071
- PMCID: PMC10182105
- DOI: 10.1007/s00330-023-09535-x
Predictive value of MRI features on glioblastoma
Conflict of interest statement
The authors have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this comment.
Comment on
-
Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.Eur Radiol. 2023 Jun;33(6):4475-4485. doi: 10.1007/s00330-022-09164-w. Epub 2022 Oct 15. Eur Radiol. 2023. PMID: 36242633 Clinical Trial.
Similar articles
-
Radiographic patterns of relapse in glioblastoma.J Neurooncol. 2011 Jan;101(2):319-23. doi: 10.1007/s11060-010-0251-4. Epub 2010 Jun 10. J Neurooncol. 2011. PMID: 21052776
-
Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.Neurosurgery. 2020 Oct 15;87(5):931-938. doi: 10.1093/neuros/nyaa135. Neurosurgery. 2020. PMID: 32365185 Free PMC article.
-
ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma.Acta Radiol. 2020 Mar;61(3):404-413. doi: 10.1177/0284185119864842. Epub 2019 Jul 29. Acta Radiol. 2020. PMID: 31357873 No abstract available.
-
Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma.Front Immunol. 2021 Nov 25;12:790674. doi: 10.3389/fimmu.2021.790674. eCollection 2021. Front Immunol. 2021. PMID: 34899760 Free PMC article. Review.
-
Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 - Radiological features and metric markers.Crit Rev Oncol Hematol. 2021 Mar;159:103230. doi: 10.1016/j.critrevonc.2021.103230. Epub 2021 Jan 27. Crit Rev Oncol Hematol. 2021. PMID: 33515701 Review.
Cited by
-
MRI-defined patterns of infiltration and outcome in patients with glioblastoma.Neurooncol Adv. 2025 Jul 11;7(1):vdaf114. doi: 10.1093/noajnl/vdaf114. eCollection 2025 Jan-Dec. Neurooncol Adv. 2025. PMID: 40842643 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical